These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 903484)
1. Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. Gallagher BM; Ansari A; Atkins H; Casella V; Christman DR; Fowler JS; Ido T; MacGregor RR; Som P; Wan CN; Wolf AP; Kuhl DE; Reivich M J Nucl Med; 1977 Oct; 18(10):990-6. PubMed ID: 903484 [TBL] [Abstract][Full Text] [Related]
2. Comparison of 2- and 3-18F-fluoro-deoxy-D-glucose for studies of tissue metabolism. Kearfott KJ; Elmaleh DR; Goodman M; Correia JA; Alpert NM; Ackerman RH; Brownell GL; Strauss WH Int J Nucl Med Biol; 1984; 11(1):15-22. PubMed ID: 6610664 [TBL] [Abstract][Full Text] [Related]
3. F-18-labeled 3-deoxy-3-fluoro-D-glucose for the study of regional metabolism in the brain and heart. Goodman MM; Elmaleh DR; Kearfott KJ; Ackerman RH; Hoop B; Brownell GL; Alpert NM; Strauss HW J Nucl Med; 1981 Feb; 22(2):138-44. PubMed ID: 6970254 [TBL] [Abstract][Full Text] [Related]
4. Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. Gallagher BM; Fowler JS; Gutterson NI; MacGregor RR; Wan CN; Wolf AP J Nucl Med; 1978 Oct; 19(10):1154-61. PubMed ID: 214528 [No Abstract] [Full Text] [Related]
5. Synthesis of, and animal experiments with, N-isopropyl-p-123I-iodo-amphetamine (IMP) and 18F-3-deoxy-3-fluoro-D-glucose (3-FDG) as tracers in brain and heart diagnostic studies. Knust EJ; Machulla HJ; Baldwin RM; Chen T; Feinendegen LE Nuklearmedizin; 1984 Feb; 23(1):31-4. PubMed ID: 6728691 [TBL] [Abstract][Full Text] [Related]
6. The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man. Jones SC; Alavi A; Christman D; Montanez I; Wolf AP; Reivich M J Nucl Med; 1982 Jul; 23(7):613-7. PubMed ID: 6979616 [TBL] [Abstract][Full Text] [Related]
7. A new method using anhydrous [18F]fluoride to radiolabel 2-[18F]fluoro-2-deoxy-D-glucose. Levy S; Elmaleh DR; Livni E J Nucl Med; 1982 Oct; 23(10):918-22. PubMed ID: 7119887 [No Abstract] [Full Text] [Related]
8. Synthesis and biodistribution of 2-deoxy-2-[18F]fluoro-D-glucopyranosyl [18F]fluoride in mice. Shiue CY; Arnett CD; Wolf AP Eur J Nucl Med; 1984; 9(2):77-80. PubMed ID: 6705813 [TBL] [Abstract][Full Text] [Related]
9. Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. Phelps ME; Hoffman EJ; Selin C; Huang SC; Robinson G; MacDonald N; Schelbert H; Kuhl DE J Nucl Med; 1978 Dec; 19(12):1311-9. PubMed ID: 104018 [No Abstract] [Full Text] [Related]
10. Experimental studies on myocardial glucose metabolism of rats with 18F-2-fluoro-2-deoxy-D-glucose. Yamada K; Endo S; Fukuda H; Abe Y; Yoshioka S; Itoh M; Kubota K; Hatazawa J; Satoh T; Matsuzawa T Eur J Nucl Med; 1985; 10(7-8):341-5. PubMed ID: 3891350 [TBL] [Abstract][Full Text] [Related]
11. Metabolic pathway of 2-deoxy-2-fluoro-D-glucose studied by F-19 NMR. Kanazawa Y; Momozono Y; Ishikawa M; Yamada T; Yamane H; Haradahira T; Maeda M; Kojima M Life Sci; 1986 Aug; 39(8):737-42. PubMed ID: 3736344 [TBL] [Abstract][Full Text] [Related]
12. Validation of 3-deoxy-3-fluoro-D-glucose as a glucose transport analogue in rat heart. Halama JR; Gatley SJ; DeGrado TR; Bernstein DR; Ng CK; Holden JE Am J Physiol; 1984 Nov; 247(5 Pt 2):H754-9. PubMed ID: 6496756 [TBL] [Abstract][Full Text] [Related]
13. A shielded synthesis system for production of 2-deoxy-2-[18F]fluoro-D-glucose. Fowler JS; MacGregor RR; Wolf AP; Farrell AA; Karlstrom KI; Ruth TJ J Nucl Med; 1981 Apr; 22(4):376-80. PubMed ID: 7205386 [TBL] [Abstract][Full Text] [Related]
14. Preparation of a fine powder of 2-deoxy-2-[18F]fluoro-D-glucose suitable for inhalation to diagnose lung diseases by means of PET. Ojima F; Ido T; Takahashi T; Hatazawa J; Ito M; Sasaki H; Yanai M; Aikawa T; Takishima T; Abiko K Ann Nucl Med; 1989 Nov; 3(3):143-7. PubMed ID: 2641460 [TBL] [Abstract][Full Text] [Related]
15. Organ and tumor distribution of (18F)-2-fluoro-2-deoxy-D-glucose in fasting and non-fasting rats. Paul R; Kiuru A; Söderström KO; Tuominen J; Johansson R; Haaparanta M; Roeda D; Solin O Life Sci; 1987 Apr; 40(16):1609-16. PubMed ID: 3031405 [TBL] [Abstract][Full Text] [Related]
17. Patterns of cerebral glucose metabolism using 18FDG and positron tomography in the neurologic investigation of the full term newborn infant. Thorp PS; Levin SD; Garnett ES; Nahmias C; Firnau G; Toi A; Upton AR; Nobbs PT; Sinclair JC Neuropediatrics; 1988 Aug; 19(3):146-53. PubMed ID: 3265490 [TBL] [Abstract][Full Text] [Related]
19. Absorbed dose estimates in positron emission tomography studies based on the administration of 18F-labeled radiopharmaceuticals. Mejia AA; Nakamura T; Itoh M; Hatazawa J; Ishiwata K; Ido T; Matsumoto M; Watabe H; Watanuki S; Seo S J Radiat Res; 1991 Sep; 32(3):243-61. PubMed ID: 1838773 [TBL] [Abstract][Full Text] [Related]
20. Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. Madar I; Ravert HT; Du Y; Hilton J; Volokh L; Dannals RF; Frost JJ; Hare JM J Nucl Med; 2006 Aug; 47(8):1359-66. PubMed ID: 16883017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]